ANOVULATORY CYCLE

This adverse event was reported 207 times

These drugs are most commonly taken by patients reporting ANOVULATORY CYCLE:

# Drug Count
0 METFORMIN 29
1 METHOTREXATE 29
2 METHOTREXATE SODIUM 29
3 HYDROXYCHLOROQUINE SULFATE 28
4 PREDNISONE 28
5 RIVAROXABAN 28
6 SULFASALAZINE 27
7 RITUXIMAB 24
8 WARFARIN 23
9 LEVONORGESTREL 22
See all common drugs associated with ANOVULATORY CYCLE

ANOVULATORY CYCLE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AZATHIOPRINE SODIUM 11 0.0043
1 CHORIONIC GONADOTROPIN 2 0.0036
2 CHORIOGONADOTROPIN ALFA 7 0.0027
3 CLOMIPHENE CITRATE 4 0.0027
4 GANIRELIX ACETATE 2 0.0026
5 MENOTROPINS 4 0.0018
6 CETRORELIX ACETATE 1 0.0016
7 NORGESTREL AND ETHINYL ESTRADIOL 1 0.0011
8 FOLLITROPIN ALFA 2 0.0010
9 ALMOTRIPTAN 1 0.0009
See all drugs enriched for association with ANOVULATORY CYCLE

ANOVULATORY CYCLE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Gonadotropin [EPC] 2 0.0009
1 Aminosalicylate [EPC] 27 0.0003
2 Purine Antimetabolite [EPC] 16 0.0002
3 Copper-containing Intrauterine Device [EPC] 7 0.0001
4 Progestin [EPC] 39 0.0001
5 Factor Xa Inhibitor [EPC] 28 0.0001
6 CD20-directed Cytolytic Antibody [EPC] 24 0.0001
7 Folate Analog Metabolic Inhibitor [EPC] 29 0.0001
8 Estrogen [EPC] 11 0.0001
9 Recombinant Human Growth Hormone [EPC] 1 0.0000
See all drug classes enriched for association with ANOVULATORY CYCLE